Company Number: 14866467

Analysis Date: 2025-07-29 16:58 UTC

Financial Health Assessment for EZIOSS LTD

---

1. Financial Health Score: B

Explanation:
EZIOSS LTD demonstrates a solid financial base with positive net assets and no current liabilities, indicating a sound start-up phase with no immediate financial distress. However, the company's scale is very small (micro-entity) and there is limited financial data to assess operational profitability or cash flow strength. The absence of liabilities and presence of net assets is encouraging, but more operational data over time is needed to confidently assign a higher grade.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£500	Minimal investment in long-term assets, typical for a new micro-entity company.
Current Assets	£500	Short-term resources available, modest but positive.
Current Liabilities	£0	No immediate debts or payables, signaling no liquidity pressure.
Net Current Assets	£500	Positive working capital, indicating liquidity to cover short-term obligations comfortably.
Total Assets less Current Liabilities	£1,500	Reflects the company's total net resources after short-term debts.
Net Assets (Shareholders Funds)	£1,500	Indicates equity invested by shareholders, showing a positive equity position with no debt.
Number of Employees	1	Very small operation, consistent with micro-entity status.

Additional notes:

• The company is active and up-to-date with filing deadlines, showing good compliance health.
• Ownership and control concentrated in one director with 75-100% shares; this is typical for a start-up and simplifies governance but may limit external capital.

---

3. Diagnosis: Financial Condition and Business Health

EZIOSS LTD exhibits the "vital signs" of a financially stable micro-entity in its infancy stage. The positive net assets and zero current liabilities suggest no symptoms of financial distress such as liquidity crunch or over-leveraging. The company’s financial structure is very simple, with minimal fixed and current assets, reflecting a "healthy but nascent" financial body.

However, the limited scale and absence of operational profit/loss data means the company’s "immune system" (ability to generate sustained revenue and profit) cannot yet be evaluated. The single employee and micro account status confirm a very early stage business, likely still establishing its market presence.

In medical analogy, the company is like a young patient with stable vital signs but under observation for development of strength and resilience through operational performance.

---

4. Recommendations for Financial Wellness Improvement

• Build Operational Revenue & Profit: Focus on growing sales and generating positive net income to strengthen retained earnings and build reserves. This will improve the company’s financial "immune system."
• Maintain Cash Flow Health: Continue to monitor working capital closely. Ensure cash inflows cover operational outflows to avoid liquidity "symptoms" such as delayed payments or overdrafts.
• Consider Asset Investment Strategically: As the business grows, evaluate need for investment in fixed assets or intangible assets (e.g., technology, branding) to support scalable operations.
• Governance and Risk Management: Although single-director control is efficient at this stage, consider establishing advisory or oversight mechanisms as business complexity grows to avoid governance "ailments."
• Prepare for Growth and Compliance: Ensure timely filings and compliance to avoid penalties and maintain market confidence. Plan ahead for transition from micro-entity accounting as business size increases.
• Explore Funding Options: If growth is capital-intensive, consider external funding or partnerships to boost equity and operational capacity.

---